Financials data is unavailable for this security.
View more
Year on year DNA Chip Research Inc grew revenues 49.74% from 327.54m to 490.46m while net income improved from a loss of 362.34m to a smaller loss of 248.29m.
Gross margin | 28.19% |
---|---|
Net profit margin | -27.41% |
Operating margin | -29.11% |
Return on assets | -20.25% |
---|---|
Return on equity | -26.00% |
Return on investment | -24.51% |
More ▼
Cash flow in JPYView more
In 2024, DNA Chip Research Inc increased its cash reserves by 41.05%, or 113.05m. Cash Flow from Financing totalled 269.05m or 54.86% of revenues. In addition the company used 140.23m for operations while cash used for investing totalled 15.78m.
Cash flow per share | -19.81 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 105.25 |
---|---|
Tangible book value per share | 86.12 |
More ▼
Balance sheet in JPYView more
Current ratio | 3.32 |
---|---|
Quick ratio | 2.98 |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼